Edition:
United Kingdom

People: Poxel SA (POXEL.PA)

POXEL.PA on Paris Stock Exchange

7.04EUR
4:35pm BST
Change (% chg)

€0.07 (+1.00%)
Prev Close
€6.97
Open
€6.98
Day's High
€7.09
Day's Low
€6.95
Volume
26,395
Avg. Vol
139,660
52-wk High
€9.18
52-wk Low
€4.92

Kender, Richard 

Mr. Richard Kender has served as a member of the board of directors of Poxel SA since 2015. He is Member of the Audit Committee and the Remuneration Committee, as well as Chairman of Business Development Committee and Member of the Strategic and Pricing Committee. Mr. Kender joined Merck & Co., Inc. in 1978, and served as Merck’s Vice President of Corporate Development from 1996 to 2000. In 2000, he was promoted to Senior Vice President and his responsibilities were expanded to include Corporate Licensing and Worldwide Business Development, where he managed Merck’s Mergers and Acquisitions, Licensing, Financial Evaluation and Analysis and Global Competitive Intelligence departments. Mr. Kender retired from Merck in September 2013. Mr. Kender currently serves on the board of directors and audit committee of Seres Therapeutics and on the board of directors of Abide Therapeutics. He holds a BS in Accounting from Villanova University and an MBA from Fairleigh Dickinson University.

Basic Compensation

Total Annual Compensation, EUR --
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 106,047
Fiscal Year Total, EUR 106,047

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --